Predicting response to immunosuppressive therapy in childhood aplastic anemia
Authors:
Open Access
- 27 January 2011
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 96 (5) , 771-774
Abstract
In aplastic anemia, predictive markers of response to immunosuppressive therapy have not been well defined. We retrospectively evaluated whether clinical and laboratory findings before treatment could predict response in a pediatric cohort from the multicenter AA-97 study in Japan. Between 1997 and 2006, 312 newly diagnosed children were enrolled and treated with a combination of antithymocyte globulin and cyclosporine. In multivariate analyses, lower white blood cell count was the most significant predictive marker of better response; patients with white blood cell count less than 2.0×109/L showed a higher response rate than those with white blood cell count of 2.0×109/L or more (P=0.0003), followed by shorter interval between diagnosis and therapy (P=0.01), and male sex (P=0.03). In conclusion, pre-treatment clinical and laboratory findings influence response to therapy. The finding that response rate worsens with increasing interval between diagnosis and treatment highlights the importance of prompt immunosuppressive therapy for patients with aplastic anemia.Keywords
This publication has 23 references indexed in Scilit:
- Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemiaEuropean Journal of Haematology, 2010
- Predicting response to immunosuppressive therapy and survival in severe aplastic anaemiaBritish Journal of Haematology, 2008
- Long-Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Antithymocyte Globulin and CyclosporineThe Journal of Pediatrics, 2008
- Clinical impact of HLA‐DR15, a minor population of paroxysmal nocturnal haemoglobinuria‐type cells, and an aplastic anaemia‐associated autoantibody in children with acquired aplastic anaemiaBritish Journal of Haematology, 2008
- Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemiaBlood, 2008
- Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow TransplantationHaematologica, 2007
- Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survivalBlood, 2005
- Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantationBritish Journal of Haematology, 2000
- Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT* SAA Working PartyBritish Journal of Haematology, 1988
- Suppression of Erythroid-Colony Formation by Lymphocytes from Patients with Aplastic AnemiaNew England Journal of Medicine, 1977